Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric TherapeuticsGlobeNewsWire • 01/02/25
Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pactMarket Watch • 12/31/24
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy PactBenzinga • 12/31/24
360 Stocks in the S&P 500 Underperformed the Benchmark's 2024 Gain of 24%. Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street.The Motley Fool • 12/29/24
Start Off the New Year With 5 Blue Chip Dividend Stocks That Pay 6% and Higher Yields24/7 Wall Street • 12/27/24
Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 12/26/24
Dividend Harvesting Portfolio Week 199: $19,900 Allocated, $1,908.79 In Projected DividendsSeeking Alpha • 12/26/24
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst ConvictionBenzinga • 12/23/24
Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024The Motley Fool • 12/23/24